KIMS
Invest with MTF
Invest Now
Invest in Krishna Institute of Medical Sciences with 3.46X leverage
Performance
- Low
- ₹652
- High
- ₹667
- 52 Week Low
- ₹474
- 52 Week High
- ₹798
- Open Price₹667
- Previous Close₹663
- Volume181,370
Investment Returns
- Over 1 Month -5.61%
- Over 3 Month -12.44%
- Over 6 Month + 1.69%
- Over 1 Year + 7.6%
Smart Investing Starts Here Start SIP with Krishna Institute of Medical Sciences for Steady Growth!
Krishna Institute of Medical Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 78.8
- PEG Ratio
- 55.7
- Market Cap Cr
- 26,475
- P/B Ratio
- Average True Range
- 19.98
- EPS
- 8.21
- Dividend Yield
- 0
- MACD Signal
- -5.18
- RSI
- 37.31
- MFI
- 47.68
Krishna Institute of Medical Sciences Financials
Krishna Institute of Medical Sciences Technicals
EMA & SMA
Current Price
₹661.65
-1.55
(-0.23%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹687.80
- 50 Day
- ₹699.06
- 100 Day
- ₹701.07
- 200 Day
- ₹675.02
Resistance and Support
670.73
- R3 707.47
- R2 697.73
- R1 680.47
- S1 653.47
- S2 643.73
- S3 626.47
Krishna Institute of Medical Sciences Corporate Actions - Bonus, Splits, Dividends
Krishna Institute of Medical Sciences F&O
About Krishna Institute of Medical Sciences
- NSE Symbol
- KIMS
- BSE Symbol
- 543308
- Chairman & Managing Director
- Dr. Bhaskara Rao Bollineni
- ISIN
- INE967H01025
Similar Stocks to Krishna Institute of Medical Sciences
Krishna Institute of Medical Sciences FAQs
Krishna Institute of Medical Sciences share price is ₹661 As on 11 December, 2025 | 10:40
The Market Cap of Krishna Institute of Medical Sciences is ₹26475.2 Cr As on 11 December, 2025 | 10:40
The P/E ratio of Krishna Institute of Medical Sciences is 78.8 As on 11 December, 2025 | 10:40
The PB ratio of Krishna Institute of Medical Sciences is 13.2 As on 11 December, 2025 | 10:40
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.